The timing of genetic testing and healthcare costs associated with the diagnostic journey of inherited retinal disease
Patients undergoing delayed vs early genetic testing incurred substantially higher HCRU. The cost to payers of genetic testing was markedly lower than the costs incurred when testing was delayed.
Authors
- Cagri G. Besirli (ORCID: https://orcid.org/0000-0001-7154-2024)
- Kirsten Lum
- Marvin Sperling
- Wenye Wang (ORCID: https://orcid.org/0000-0001-7892-3196)
- Ji-Eun Song (ORCID: https://orcid.org/0000-0002-0529-1084)
- Qiaoyi Zhang (ORCID: https://orcid.org/0000-0002-7482-5270)
- Qian Cai
- Ting Wu (ORCID: https://orcid.org/0000-0002-4056-6514)
- Michael Clark (ORCID: https://orcid.org/0000-0003-4949-1608)
Institutions
- Johnson & Johnson (United States) (US)
- Johnson & Johnson (Israel) (IL)
Publication Details
- Journal
- Ophthalmic Genetics
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1080/13816810.2025.2591826
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00